Estimation of prognostic value of CD44 expression in neuroblastic tumours in children

Folia Neuropathologica

Volumn 45, Issue 3, 2007, Pages 126-132

  Taran, Katarzyna ^a   Kobos, Józef ^a   Sitkiewicz, Anna ^a   Sporny, Stanisław ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

CD44; Neuroblastoma; Prognostic factors; Survival time

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; HERMES ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER RELAPSE; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; KAPLAN MEIER METHOD; LOG RANK TEST; MALE; MEDICAL RECORD; NEUROBLASTOMA; PROGNOSIS; RETROPERITONEAL TUMOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TISSUE SECTION;

EID: 34948828535     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alva E, Gerald WL. Approach to small round cell tumors of childhood. Pathol Case Rev 2000; 5: 26-41.
2. Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 2005; 353: 2243-2253.
3. Berthold F, Sahin K, Hero B, Christiansen H, Gehring M, Harms D, Horz S, Lampert F, Schwab M, Terpe J. The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur J Cancer 1997; 33: 2092-2097.
4. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee RE, Look AT, Pearson DJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA. Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging, and Response to Treatment. J Clin Oncol 1993; 11: 1466-1477.
5. Cheung NK, Kushner BH, LaQuaglia MP, Kramer K, Ambros P, Ambros I, Ladanyi M, Eddy J, Bonilla MA, Gerald W. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. Eur J Cancer 1997; 33: 2117-2120.
6. Citak C, Karadeniz C, Dalgic B, Oguz A, Poyraz A, Okur V, Boyunaga O. Intestinal lymphangiectasia as a first manifestation of neuroblastoma. Pediatr Blood Cancer 2006; 46: 105-107.
7. Combaret V, Gross N, Lasset C, Balmas K, Bouvier R, Frappaz D, Beretta-Brognara C, Philip T, Favrot MC, Coll JL. Clinical revelance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression. Br J Cancer 1997; 75: 1151-1155.
8. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, Beck D, Favrot MC. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 1996; 14: 25-34.
9. Combaret V, Gross N, Lasset C, Frappaz D, Beretta-Brognara C, Philip T, Beck D, Favrot MC. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. Eur J Cancer 1997; 33: 2101-2105.
10. Comito MA, Savell VH, Cohen MB. CD44 expression in neuroblastoma and related tumors. J Pediatr Hematol Oncol 1997; 19: 292-296.
11. Conte M, Parodi S, De Bernardi B, Milanaccio C, Mazzocco K, Angelini P, Viscardi E, Di Cataldo A, Luksch R, Haupt R. Neuroblastoma in adolescents: the Italian experience. Cancer 2006; 106: 1409-1417.
12. Da Silva J, Duarte N, Cappellen D, Bettan-Renaud L, Dubourg C, Ferrandis E, Guigay J, Schrodt S, McDowell H, Barrois M, Ahomadegbe JC, Terrier-Lacombe MJ, Bourhis J, Hartmann O, Benard J. Facteurs oncogeniques de la dissemination metastatique du neuroblasto. C R Seances Soc Biol Fil 1998; 192: 261-271.
13. Eggert A, Grotzer MA, Zhao H, Brodeur GM, Evans AE. Die Expression des Neurotrophin-Rezeptors TrkB beeinflusst die Prognose von Nephroblastomen: Ergebnisse eier Pilotstudie. Klin Padiatr 2001; 213: 191-196.
14. Fichter M, Hinrichs R, Eissner G, Scheffer B, Classen S, Ueffing M. Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C. Oncogene 1997; 14: 2817-2824.
15. Gross N, Balmas K, Beretta Brognara C. Role of CD44H carbohydrate structure in neuroblastoma adhesive properties. Med Pediatr Oncol 2001; 36: 139-141.
16. Gross N, Balmas K, Brognara C. Absence of functional CD44 receptor on human NMYC-amplified neuroblastoma cells. Cancer Res 1997; 57: 1387-1393.
17. Gross N, Balmas Bourloud K, Brognara CB. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells. Exp Cell Res 2000; 260: 396-403.
18. Haber M, Smith J, Bordow SB, Flemming C, Cohn SL, London WB, Marshall GM, Norris MD. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. J Clin Oncol 2006; 24: 1546-1553.
19. Hoehner JC, Hedborg F, Eriksson L, Sandstedt B, Grimelius L, Olsen L, Pahlman S. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab Invest 1998; 78: 29-45.
20. Joshi VV, Tsongalis GJ. Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma. Ann N Y Acad Sci 1997; 824: 71-83.
21. Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS; United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group. Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol 2001; 19: 3080-3090.
22. Llombart Bosch A, O'Neill S, Mazzocca K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS. Small round cell tumors. A challenge for surgical pathology: Past and future. Rev Esp Patol 1999; 32: 259-260.
23. Masson D, Denis MG, Denis M, Blanchard D, Loirat MJ, Cassagnau E, Lustenberger P. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer. B J Cancer 1999; 80: 1995-2000.
24. Maula S, Huuhtanen RL, Blomqvist CP, Wiklund TA, Laurila P, Ristamaki R. The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas. B J Cancer 2001; 84: 244-252.
25. Ohali A, Avigad S, Ash S, Goshen Y, Luria D, Feinmesser M, Zaizov R, Yaniv I. Telomere length is a prognostic factor in neuroblastoma. Cancer 2006; 107: 1391-1399.
26. Papierz W, Liberski P. Nowotwory osłonek nerwów czaszkowych i nerwów obwodowych. Pol J Pathol 2001; 53: 63-64.
27. Pfeifer JD, Hill DA, O'Sullivan MJ, Dehner LP. Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology 2000; 37: 485-500.
28. Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Bénard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J, Sommelet D. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 1997; 15: 1171-1182.
29. Setala L, Lipponen P, Tammi R, Tammi M, Eskelinen M, Alhava F, Kosma VM. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Histopathology 2001; 38: 13-20.
30. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Strain DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86: 364-372.